Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)
Nick Thatcher(The Christie Hospital), Alex Y. Chang, Purvish M. Parikh(Tata Memorial Hospital), José Rodrigues Pereira, Tudor–Eliade Ciuleanu(Institute of Oncology Prof. Dr. Ion Chiricuta), Joachim von Pawel(Asklepios Fachkliniken München-Gauting), Sumitra Thongprasert(Maharaj Nakorn Chiang Mai Hospital), E.H. Tan(National Cancer Centre Singapore), Kristine Pemberton(AstraZeneca (United Kingdom)), Venice Archer(AstraZeneca (United Kingdom)), Kevin Carroll(AstraZeneca (United Kingdom))
Cited by 2,088
Abstract
Related Papers
No related papers found
Powered by citation graph analysis